Menu
Search
|

Menu

Close
X

Odonate Therapeutics Inc ODT.OQ (NASDAQ Stock Exchange Global Select Market)

24.95 USD
+2.21 (+9.72%)
As of Feb 16
chart
Previous Close 22.74
Open 22.71
Volume 49,515
3m Avg Volume --
Today’s High 24.95
Today’s Low 22.51
52 Week High 25.30
52 Week Low 15.15
Shares Outstanding (mil) 26.89
Market Capitalization (mil) 670.91
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
0
EPS (USD)
FY17
-0.641
FY16
-0.073
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
--
8.57
Price to Book (MRQ)
vs sector
9.04
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
0.00
15.12
LT Debt to Equity (MRQ)
vs sector
0.00
11.85
Return on Investment (TTM)
vs sector
--
13.54
Return on Equity (TTM)
vs sector
--
14.80

EXECUTIVE LEADERSHIP

Kevin Tang
Chairman of the Board, Chief Executive Officer, Since 2013
Salary: $1.00
Bonus: --
Jeff Vacirca
Vice Chairman of the Board, Since 2016
Salary: --
Bonus: --
John Lemkey
Chief Financial Officer, Since 2013
Salary: --
Bonus: --
Robert Millham
Chief Operating Officer, Since 2017
Salary: --
Bonus: --
Stewart Kroll
Senior Vice President - Biometrics, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

4747 Executive Dr Ste 510
SAN DIEGO   CA   92121-3100

Phone: +1858.2003830

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

SPONSORED STORIES